Sandip Kapadia, CHIEF FINANCIAL OFFICER at Harmony Biosciences Holdings, Inc. (HRMY), sold 25,000 shares at $40.18 ($1.0M) on 2025-01-21, disclosed to the SEC on 2025-01-23.
Scheduled sale ($1.0M) by CHIEF FINANCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| HRMY | SELL | 2025-12-09 | $791K | — | Filing → |
| HRMY | SELL | 2025-11-25 | $120K | — | Filing → |
| HRMY | SELL | 2025-08-19 | $1.6M | — | Filing → |